Wealthcare Advisory Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Wealthcare Advisory Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-400	Closed	–	–	1643
2019 Q4	$0	Hold	400	–	–	﹤0.01%	1485
2019 Q3	$0	Hold	400	–	–	﹤0.01%	1465
2019 Q2	$0	Hold	400	–	–	﹤0.01%	1397
2019 Q1	$0	Hold	400	–	–	﹤0.01%	1328
2018 Q4	$0	Hold	400	–	–	﹤0.01%	1340
2018 Q3	$0	Hold	400	–	–	﹤0.01%	1357
2018 Q2	$0	Buy	+400	New	+$186	﹤0.01%	1379

Wealthcare Advisory Partners's GCVRZ Position: Q1 2020 in Review

Wealthcare Advisory Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 400 shares.

Wealthcare Advisory Partners first reported a position in GCVRZ in Q2 2018 and held it in 7 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Wealthcare Advisory Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Wealthcare Advisory Partners sold 400 Sanofi Contingent Value Rights shares in Q1 2020.
Wealthcare Advisory Partners first reported a position in Sanofi Contingent Value Rights in Q2 2018 and held it in 7 quarters.
Wealthcare Advisory Partners's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2020, filed 29 Apr 2020.